{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:07:40Z","timestamp":1793675260561,"version":"4.5.1"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s40257-017-0333-6","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T01:19:01Z","timestamp":1512695941000},"page":"489-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":137,"title":["Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8195-5324","authenticated-orcid":false,"given":"Bridget P.","family":"Kaufman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taulun","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Alexis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"issue":"6 Suppl","key":"333_CR1","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1067\/mjd.2003.274","volume":"48","author":"RM Halder","year":"2003","unstructured":"Halder RM, Nootheti PK. Ethnic skin disorders overview. J Am Acad Dermatol. 2003;48(6 Suppl):S143\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"333_CR2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2310\/7750.2009.08077","volume":"13","author":"S Taylor","year":"2009","unstructured":"Taylor S, Grimes P, Lim J, Im S, Lui H. Postinflammatory hyperpigmentation. J Cutan Med Surg. 2009;13(4):183\u201391.","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"333_CR3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-4632.2004.02267.x","volume":"43","author":"NL Lacz","year":"2004","unstructured":"Lacz NL, Vafaie J, Kihiczak NI, Schwartz RA. Postinflammatory hyperpigmentation: a common but troubling condition. Int J Dermatol. 2004;43(5):362\u20135.","journal-title":"Int J Dermatol"},{"issue":"5","key":"333_CR4","first-page":"18","volume":"10","author":"K Darji","year":"2017","unstructured":"Darji K, Varade R, West D, Armbrecht ES, Guo MA. Psychosocial impact of postinflammatory hyperpigmentation in patients with acne vulgaris. J Clin Aesthet Dermatol. 2017;10(5):18\u201323.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"333_CR5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1524-4725.2009.01103.x","volume":"35","author":"SS Joshi","year":"2009","unstructured":"Joshi SS, Boone SL, Alam M, Yoo S, White L, Rademaker A, et al. Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin. Dermatol Surg. 2009;35(4):638\u201344 (discussion 44).","journal-title":"Dermatol Surg"},{"issue":"7","key":"333_CR6","first-page":"19","volume":"7","author":"VD Callender","year":"2014","unstructured":"Callender VD, Alexis AF, Daniels SR, Kawata AK, Burk CT, Wilcox TK, et al. Racial differences in clinical characteristics, perceptions and behaviors, and psychosocial impact of adult female acne. J Clin Aesthet Dermatol. 2014;7(7):19\u201331.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"333_CR7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/DSS.0000000000000627","volume":"42","author":"JH Park","year":"2016","unstructured":"Park JH, Kim JI, Kim WS. Treatment of persistent facial postinflammatory hyperpigmentation with novel pulse-in-pulse mode intense pulsed light. Dermatol Surg. 2016;42(2):218\u201324.","journal-title":"Dermatol Surg"},{"issue":"6","key":"333_CR8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaad.2007.01.031","volume":"56","author":"D El-Essawi","year":"2007","unstructured":"El-Essawi D, Musial JL, Hammad A, Lim HW. A survey of skin disease and skin-related issues in Arab Americans. J Am Acad Dermatol. 2007;56(6):933\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"333_CR9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0733-8635(03)00087-1","volume":"21","author":"MR Sanchez","year":"2003","unstructured":"Sanchez MR. Cutaneous diseases in Latinos. Dermatol Clin. 2003;21(4):689\u201397.","journal-title":"Dermatol Clin"},{"issue":"4","key":"333_CR10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-4362.2003.01358.x","volume":"42","author":"P Dunwell","year":"2003","unstructured":"Dunwell P, Rose A. Study of the skin disease spectrum occurring in an Afro-Caribbean population. Int J Dermatol. 2003;42(4):287\u20139.","journal-title":"Int J Dermatol"},{"issue":"5","key":"333_CR11","first-page":"387","volume":"80","author":"AF Alexis","year":"2007","unstructured":"Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007;80(5):387\u201394.","journal-title":"Cutis"},{"issue":"4","key":"333_CR12","first-page":"466","volume":"11","author":"SA Davis","year":"2012","unstructured":"Davis SA, Narahari S, Feldman SR, Huang W, Pichardo-Geisinger RO, McMichael AJ. Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol. 2012;11(4):466\u201373.","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"333_CR13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/09546630410033790","volume":"15","author":"R Balkrishnan","year":"2004","unstructured":"Balkrishnan R, Feldman SR, McMichael AJ, DeHart KE, Cayce K, Fleischer AB Jr. Racial differences in the treatment of pigmentation disorders in outpatient settings: analysis of US national practice data. J Dermatol Treat. 2004;15(4):227\u201330.","journal-title":"J Dermatol Treat"},{"issue":"8","key":"333_CR14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-4362.1992.tb02717.x","volume":"31","author":"G Chua-Ty","year":"1992","unstructured":"Chua-Ty G, Goh CL, Koh SL. Pattern of skin diseases at the National Skin Centre (Singapore) from 1989\u20131990. Int J Dermatol. 1992;31(8):555\u20139.","journal-title":"Int J Dermatol"},{"issue":"1","key":"333_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0733-8635(05)70150-9","volume":"18","author":"AG Pandya","year":"2000","unstructured":"Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin. 2000;18(1):91\u201398 ix.","journal-title":"Dermatol Clin"},{"issue":"1","key":"333_CR16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1085-5629(97)80034-X","volume":"16","author":"R Ruiz-Maldonado","year":"1997","unstructured":"Ruiz-Maldonado R, Orozco-Covarrubias ML. Postinflammatory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg. 1997;16(1):36\u201343.","journal-title":"Semin Cutan Med Surg"},{"issue":"34","key":"333_CR17","doi-asserted-by":"crossref","first-page":"24675","DOI":"10.1016\/S0021-9258(18)35817-4","volume":"267","author":"G Imokawa","year":"1992","unstructured":"Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem. 1992;267(34):24675\u201380.","journal-title":"J Biol Chem"},{"issue":"2","key":"333_CR18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/11536930-000000000-00000","volume":"12","author":"VD Callender","year":"2011","unstructured":"Callender VD, St Surin-Lord S, Davis EC, Maclin M. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol. 2011;12(2):87\u201399.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"333_CR19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaad.2013.09.017","volume":"70","author":"SA Savory","year":"2014","unstructured":"Savory SA, Agim NG, Mao R, Peter S, Wang C, Maldonado G, et al. Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris. J Am Acad Dermatol. 2014;70(1):108\u201314.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"333_CR20","first-page":"45","volume":"77","author":"P Grimes","year":"2006","unstructured":"Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis. 2006;77(1):45\u201350.","journal-title":"Cutis"},{"issue":"6","key":"333_CR21","first-page":"362","volume":"74","author":"PE Grimes","year":"2004","unstructured":"Grimes PE. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation. Cutis. 2004;74(6):362\u20138.","journal-title":"Cutis"},{"issue":"20","key":"333_CR22","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199305203282002","volume":"328","author":"SM Bulengo-Ransby","year":"1993","unstructured":"Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, Finkel LJ, Hamilton TA, Ellis CN, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med. 1993;328(20):1438\u201343.","journal-title":"N Engl J Med"},{"issue":"5","key":"333_CR23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0149-2918(98)80076-3","volume":"20","author":"NJ Lowe","year":"1998","unstructured":"Lowe NJ, Rizk D, Grimes P, Billips M, Pincus S. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther. 1998;20(5):945\u201359.","journal-title":"Clin Ther"},{"issue":"4","key":"333_CR24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/bjd.14184","volume":"174","author":"P Isedeh","year":"2016","unstructured":"Isedeh P, Kohli I, Al-Jamal M, Agbai ON, Chaffins M, Devpura S, et al. An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits. Br J Dermatol. 2016;174(4):862\u20138.","journal-title":"Br J Dermatol"},{"key":"333_CR25","first-page":"149","volume":"17","author":"F Cook-Bolden","year":"2004","unstructured":"Cook-Bolden F. The efficacy and tolerability of combination cream containing 4% hydroquinone in the treatment of postinflammatory hyperpigmentation in skin types IV\u2013VI. Cosmetic Dermatol. 2004;17:149\u201355.","journal-title":"Cosmetic Dermatol"},{"issue":"2","key":"333_CR26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/cup.12849","volume":"44","author":"JY Park","year":"2017","unstructured":"Park JY, Park JH, Kim SJ, Kwon JE, Kang HY, Lee ES, et al. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal. J Cutan Pathol. 2017;44(2):118\u201324.","journal-title":"J Cutan Pathol"},{"issue":"2","key":"333_CR27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.sder.2009.04.001","volume":"28","author":"PE Grimes","year":"2009","unstructured":"Grimes PE. Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg. 2009;28(2):77\u201385.","journal-title":"Semin Cutan Med Surg"},{"issue":"5","key":"333_CR28","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1073\/pnas.90.5.1790","volume":"90","author":"EE Medrano","year":"1993","unstructured":"Medrano EE, Farooqui JZ, Boissy RE, Boissy YL, Akadiri B, Nordlund JJ. Chronic growth stimulation of human adult melanocytes by inflammatory mediators in vitro: implications for nevus formation and initial steps in melanocyte oncogenesis. Proc Natl Acad Sci USA. 1993;90(5):1790\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5 Pt 2","key":"333_CR29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-0749.1992.tb00562.x","volume":"5","author":"Y Tomita","year":"1992","unstructured":"Tomita Y, Maeda K, Tagami H. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res. 1992;5(5 Pt 2):357\u201361.","journal-title":"Pigment Cell Res"},{"issue":"2","key":"333_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0738-081X(89)90057-6","volume":"7","author":"JH Epstein","year":"1989","unstructured":"Epstein JH. Postinflammatory hyperpigmentation. Clin Dermatol. 1989;7(2):55\u201365.","journal-title":"Clin Dermatol"},{"issue":"4","key":"333_CR31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0738-081X(97)00072-2","volume":"15","author":"T Ebihara","year":"1997","unstructured":"Ebihara T, Nakayama H. Pigmented contact dermatitis. Clin Dermatol. 1997;15(4):593\u20139.","journal-title":"Clin Dermatol"},{"issue":"2 Suppl Underst","key":"333_CR32","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1067\/mjd.2002.120791","volume":"46","author":"SC Taylor","year":"2002","unstructured":"Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46(2 Suppl Understanding):S98\u2013106.","journal-title":"J Am Acad Dermatol"},{"key":"333_CR33","first-page":"888","volume":"106","author":"RM Halder","year":"1996","unstructured":"Halder RM, Holmes YC, Bridgeman-Shah S, Kligman AM. A clinicohistopathological study of acne vulgaris in black females. J Invest Dermatol. 1996;106:888 [abstract 495].","journal-title":"J Invest Dermatol"},{"issue":"1","key":"333_CR34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40257-013-0049-1","volume":"15","author":"NC Yin","year":"2014","unstructured":"Yin NC, McMichael AJ. Acne in patients with skin of color: practical management. Am J Clin Dermatol. 2014;15(1):7\u201316.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"333_CR35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/09546630903401496","volume":"21","author":"SK Shah","year":"2010","unstructured":"Shah SK, Alexis AF. Acne in skin of color: practical approaches to treatment. J Dermatolog Treat. 2010;21(3):206\u201311.","journal-title":"J Dermatolog Treat"},{"issue":"2 Suppl Underst","key":"333_CR36","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1067\/mjd.2002.120789","volume":"46","author":"PK Perry","year":"2002","unstructured":"Perry PK, Cook-Bolden FE, Rahman Z, Jones E, Taylor SC. Defining pseudofolliculitis barbae in 2001: a review of the literature and current trends. J Am Acad Dermatol. 2002;46(2 Suppl Understanding):S113\u20139.","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"333_CR37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000362596","volume":"229","author":"AC Seghers","year":"2014","unstructured":"Seghers AC, Lee JS, Tan CS, Koh YP, Ho MS, Lim YL, et al. Atopic dirty neck or acquired atopic hyperpigmentation? An epidemiological and clinical study from the National Skin Centre in Singapore. Dermatology. 2014;229(3):174\u201382.","journal-title":"Dermatology"},{"issue":"11","key":"333_CR38","first-page":"16","volume":"7","author":"AF Alexis","year":"2014","unstructured":"Alexis AF, Blackcloud P. Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances. J Clin Aesthet Dermatol. 2014;7(11):16\u201324.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"333_CR39","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/DSS.0000000000000640","volume":"42","author":"AF Alexis","year":"2016","unstructured":"Alexis AF, Coley MK, Nijhawan RI, Luke JD, Shah SK, Argobi YA, et al. Nonablative fractional laser resurfacing for acne scarring in patients with fitzpatrick skin phototypes IV\u2013VI. Dermatol Surg. 2016;42(3):392\u2013402.","journal-title":"Dermatol Surg"},{"issue":"7","key":"333_CR40","first-page":"551","volume":"28","author":"EL Tanzi","year":"2002","unstructured":"Tanzi EL, Alster TS. Treatment of atrophic facial acne scars with a dual-mode Er: YAG laser. Dermatol Surg. 2002;28(7):551\u20135.","journal-title":"Dermatol Surg"},{"issue":"4","key":"333_CR41","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1097\/01.PRS.0000049647.65948.50","volume":"111","author":"EL Tanzi","year":"2003","unstructured":"Tanzi EL, Alster TS. Side effects and complications of variable-pulsed erbium:yttrium-aluminum-garnet laser skin resurfacing: extended experience with 50 patients. Plast Reconstr Surg. 2003;111(4):1524\u20139 (discussion 30\u20132).","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"333_CR42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/lsm.20512","volume":"39","author":"HH Chan","year":"2007","unstructured":"Chan HH, Manstein D, Yu CS, Shek S, Kono T, Wei WI. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med. 2007;39(5):381\u20135.","journal-title":"Lasers Surg Med"},{"issue":"4","key":"333_CR43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/lsm.20484","volume":"39","author":"T Kono","year":"2007","unstructured":"Kono T, Chan HH, Groff WF, Manstein D, Sakurai H, Takeuchi M, et al. Prospective direct comparison study of fractional resurfacing using different fluences and densities for skin rejuvenation in Asians. Lasers Surg Med. 2007;39(4):311\u20134.","journal-title":"Lasers Surg Med"},{"issue":"5","key":"333_CR44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1524-4725.2011.01957.x","volume":"37","author":"H Kato","year":"2011","unstructured":"Kato H, Araki J, Eto H, Doi K, Hirai R, Kuno S, et al. A prospective randomized controlled study of oral tranexamic acid for preventing postinflammatory hyperpigmentation after Q-switched ruby laser. Dermatol Surg. 2011;37(5):605\u201310.","journal-title":"Dermatol Surg."},{"issue":"5","key":"333_CR45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1524-4725.2011.01958.x","volume":"37","author":"DH McDaniel","year":"2011","unstructured":"McDaniel DH. Use of oral therapy for the prevention of postinflammatory hyperpigmentation. Dermatol Surg. 2011;37(5):611.","journal-title":"Dermatol Surg"},{"issue":"2","key":"333_CR46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2340\/00015555-1899","volume":"95","author":"N Cheyasak","year":"2015","unstructured":"Cheyasak N, Manuskiatti W, Maneeprasopchoke P, Wanitphakdeedecha R. Topical corticosteroids minimise the risk of postinflammatory hyper-pigmentation after ablative fractional CO2 laser resurfacing in Asians. Acta Derm Venereol. 2015;95(2):201\u20135.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"333_CR47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/DSS.0000000000000197","volume":"41","author":"GH Park","year":"2015","unstructured":"Park GH, Rhee do Y, Moon HR, Won CH, Lee MW, Choi JH, et al. Effect of an epidermal growth factor-containing cream on postinflammatory hyperpigmentation after Q-switched 532-nm neodymium-doped yttrium aluminum garnet laser treatment. Dermatol Surg. 2015;41(1):131\u20135.","journal-title":"Dermatol Surg."},{"issue":"4","key":"333_CR48","first-page":"428","volume":"12","author":"CM Clark","year":"2013","unstructured":"Clark CM, Silverberg JI, Alexis AF. A retrospective chart review to assess the safety of nonablative fractional laser resurfacing in Fitzpatrick skin types IV to VI. J Drugs Dermatol. 2013;12(4):428\u201331.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"333_CR49","first-page":"51","volume":"10","author":"SB Kaushik","year":"2017","unstructured":"Kaushik SB, Alexis AF. Nonablative fractional laser resurfacing in skin of color: evidence-based review. J Clin Aesthet Dermatol. 2017;10(6):51\u201367.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"Suppl 3","key":"333_CR50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/bjd.12526","volume":"169","author":"AF Alexis","year":"2013","unstructured":"Alexis AF. Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. Br J Dermatol. 2013;169(Suppl 3):91\u20137.","journal-title":"Br J Dermatol"},{"issue":"1","key":"333_CR51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1524-4725.2010.01835.x","volume":"37","author":"Z Draelos","year":"2011","unstructured":"Draelos Z. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream. Dermatol Surg. 2011;37(1):126\u20137.","journal-title":"Dermatol Surg"},{"issue":"9","key":"333_CR52","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1524-4725.2010.01643.x","volume":"36","author":"S Kim","year":"2010","unstructured":"Kim S, Cho KH. Treatment of facial postinflammatory hyperpigmentation with facial acne in Asian patients using a Q-switched neodymium-doped yttrium aluminum garnet laser. Dermatol Surg. 2010;36(9):1374\u201380.","journal-title":"Dermatol Surg"},{"issue":"3","key":"333_CR53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1468-3083.2011.04385.x","volume":"27","author":"K Negishi","year":"2013","unstructured":"Negishi K, Akita H, Tanaka S, Yokoyama Y, Wakamatsu S, Matsunaga K. Comparative study of treatment efficacy and the incidence of post-inflammatory hyperpigmentation with different degrees of irradiation using two different quality-switched lasers for removing solar lentigines on Asian skin. J Eur Acad Dermatol Venereol. 2013;27(3):307\u201312.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"333_CR54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/09546634.2016.1254330","volume":"28","author":"HJ Kang","year":"2017","unstructured":"Kang HJ, Na JI, Lee JH, Roh MR, Ko JY, Chang SE. Postinflammatory hyperpigmentation associated with treatment of solar lentigines using a Q-Switched 532-nm Nd: YAG laser: a multicenter survey. J Dermatol Treat. 2017;28(5):447\u201351.","journal-title":"J Dermatol Treat."},{"issue":"3","key":"333_CR55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1524-4725.1998.tb04161.x","volume":"24","author":"CA Nanni","year":"1998","unstructured":"Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing. An evaluation of 500 patients. Dermatol Surg. 1998;24(3):315\u201320.","journal-title":"Dermatol Surg"},{"issue":"5","key":"333_CR56","first-page":"383","volume":"28","author":"MM Al-Waiz","year":"2002","unstructured":"Al-Waiz MM, Al-Sharqi AI. Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals. Dermatol Surg. 2002;28(5):383\u20137.","journal-title":"Dermatol Surg"},{"issue":"Suppl 3","key":"333_CR57","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bjd.12535","volume":"169","author":"A Salam","year":"2013","unstructured":"Salam A, Dadzie OE, Galadari H. Chemical peeling in ethnic skin: an update. Br J Dermatol. 2013;169(Suppl 3):82\u201390.","journal-title":"Br J Dermatol"},{"issue":"6","key":"333_CR58","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jaad.2009.12.027","volume":"63","author":"S Kodali","year":"2010","unstructured":"Kodali S, Guevara IL, Carrigan CR, Daulat S, Blanco G, Boker A, et al. A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women. J Am Acad Dermatol. 2010;63(6):1030\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"333_CR59","first-page":"891","volume":"34","author":"T Dainichi","year":"2008","unstructured":"Dainichi T, Ueda S, Imayama S, Furue M. Excellent clinical results with a new preparation for chemical peeling in acne: 30% salicylic acid in polyethylene glycol vehicle. Dermatol Surg. 2008;34(7):891\u20139 (discussion 9).","journal-title":"Dermatol Surg."},{"issue":"12","key":"333_CR60","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/DSS.0000000000000522","volume":"41","author":"AM Abdel Meguid","year":"2015","unstructured":"Abdel Meguid AM, Elaziz Ahmed Attallah DA, Omar H. Trichloroacetic acid versus salicylic acid in the treatment of acne vulgaris in dark-skinned patients. Dermatol Surg. 2015;41(12):1398\u2013404.","journal-title":"Dermatol Surg"},{"issue":"1","key":"333_CR61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1524-4725.1999.08145.x","volume":"25","author":"PE Grimes","year":"1999","unstructured":"Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25(1):18\u201322.","journal-title":"Dermatol Surg"},{"issue":"1","key":"333_CR62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1524-4725.1997.tb00003.x","volume":"23","author":"CM Wang","year":"1997","unstructured":"Wang CM, Huang CL, Hu CT, Chan HL. The effect of glycolic acid on the treatment of acne in Asian skin. Dermatol Surg. 1997;23(1):23\u20139.","journal-title":"Dermatol Surg"},{"issue":"8","key":"333_CR63","first-page":"1032","volume":"34","author":"VK Garg","year":"2008","unstructured":"Garg VK, Sarkar R, Agarwal R. Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels. Dermatol Surg. 2008;34(8):1032\u20139 (discussion 340).","journal-title":"Dermatol Surg."},{"issue":"6","key":"333_CR64","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2147\/CCID.S34029","volume":"11","author":"J Sharad","year":"2013","unstructured":"Sharad J. Glycolic acid peel therapy\u2014a current review. Clin Cosmet Investig Dermatol. 2013;11(6):281\u20138.","journal-title":"Clin Cosmet Investig Dermatol."},{"issue":"3","key":"333_CR65","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/DSS.0000000000000642","volume":"42","author":"R Sarkar","year":"2016","unstructured":"Sarkar R, Garg V, Bansal S, Sethi S, Gupta C. Comparative evaluation of efficacy and tolerability of glycolic acid, salicylic mandelic acid, and phytic acid combination peels in melasma. Dermatol Surg. 2016;42(3):384\u201391.","journal-title":"Dermatol Surg"},{"issue":"8","key":"333_CR66","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1365-2230.2009.03291.x","volume":"34","author":"G Fabbrocini","year":"2009","unstructured":"Fabbrocini G, Fardella N, Monfrecola A, Proietti I, Innocenzi D. Acne scarring treatment using skin needling. Clin Exp Dermatol. 2009;34(8):874\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"333_CR67","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1524-4725.2010.01854.x","volume":"37","author":"T Leheta","year":"2011","unstructured":"Leheta T, El Tawdy A, Abdel Hay R, Farid S. Percutaneous collagen induction versus full-concentration trichloroacetic acid in the treatment of atrophic acne scars. Dermatol Surg. 2011;37(2):207\u201316.","journal-title":"Dermatol Surg"},{"issue":"1","key":"333_CR68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0974-2077.53096","volume":"2","author":"I Majid","year":"2009","unstructured":"Majid I. Microneedling therapy in atrophic facial scars: an objective assessment. J Cutan Aesthet Surg. 2009;2(1):26\u201330.","journal-title":"J Cutan Aesthet Surg."},{"issue":"4","key":"333_CR69","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1473-2165.2011.00583.x","volume":"10","author":"J Sharad","year":"2011","unstructured":"Sharad J. Combination of microneedling and glycolic acid peels for the treatment of acne scars in dark skin. J Cosmet Dermatol. 2011;10(4):317\u201323.","journal-title":"J Cosmet Dermatol."},{"issue":"3","key":"333_CR70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/jocd.12095","volume":"13","author":"S Dogra","year":"2014","unstructured":"Dogra S, Yadav S, Sarangal R. Microneedling for acne scars in Asian skin type: an effective low cost treatment modality. J Cosmet Dermatol. 2014;13(3):180\u20137.","journal-title":"J Cosmet Dermatol."},{"issue":"2","key":"333_CR71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/09546634.2012.674192","volume":"25","author":"TM Leheta","year":"2014","unstructured":"Leheta TM, Abdel Hay RM, El Garem YF. Deep peeling using phenol versus percutaneous collagen induction combined with trichloroacetic acid 20% in atrophic post-acne scars; a randomized controlled trial. J Dermatol Treat. 2014;25(2):130\u20136.","journal-title":"J Dermatol Treat."},{"issue":"7","key":"333_CR72","first-page":"20","volume":"3","author":"EC Davis","year":"2010","unstructured":"Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20\u201331.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"5 Suppl","key":"333_CR73","first-page":"AB215","volume":"72","author":"R Halder","year":"2015","unstructured":"Halder R, Munhutu M, Foltis P, Battie C, Verschoore M, Oresajo C. Evaluation and effectiveness of photoprotection composition (sunscreen) on subjects of skin of color (abstract). J Am Acad Dermatol. 2015;72(5 Suppl):AB215.","journal-title":"J Am Acad Dermatol."},{"issue":"5","key":"333_CR74","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jaad.2016.12.018","volume":"76","author":"MBC Maymone","year":"2017","unstructured":"Maymone MBC, Neamah HH, Wirya SA, Patzelt NM, Zancanaro PQ, Vashi NA. Sun-protective behaviors in patients with cutaneous hyperpigmentation: a cross-sectional study. J Am Acad Dermatol. 2017;76(5):841\u2013846.e2.","journal-title":"J Am Acad Dermatol."},{"issue":"7","key":"333_CR75","first-page":"25","volume":"5","author":"VD Callender","year":"2012","unstructured":"Callender VD, Young CM, Kindred C, Taylor SC. Efficacy and safety of clindamycin phosphate 1.2% and tretinoin 0.025% gel for the treatment of acne and acne-induced post-inflammatory hyperpigmentation in patients with skin of color. J Clin Aesthet Dermatol. 2012;5(7):25\u201332.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"6","key":"333_CR76","first-page":"586","volume":"10","author":"LH Kircik","year":"2011","unstructured":"Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10(6):586\u201390.","journal-title":"J Drugs Dermatol"},{"issue":"2 Pt 3","key":"333_CR77","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/S0190-9622(98)70455-4","volume":"39","author":"RM Halder","year":"1998","unstructured":"Halder RM. The role of retinoids in the management of cutaneous conditions in blacks. J Am Acad Dermatol. 1998;39(2 Pt 3):S98\u2013103.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"333_CR78","first-page":"243","volume":"70","author":"J Czernielewski","year":"2002","unstructured":"Czernielewski J, Poncet M, Mizzi F. Efficacy and cutaneous safety of adapalene in black patients versus white patients with acne vulgaris. Cutis. 2002;70(4):243\u20138.","journal-title":"Cutis"},{"issue":"4 Suppl","key":"333_CR79","first-page":"55","volume":"68","author":"XJ Zhu","year":"2001","unstructured":"Zhu XJ, Tu P, Zhen J, Duan YQ. Adapalene gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients. Cutis. 2001;68(4 Suppl):55\u20139.","journal-title":"Cutis."},{"issue":"1 Suppl","key":"333_CR80","first-page":"15","volume":"80","author":"SC Taylor","year":"2007","unstructured":"Taylor SC. Utilizing combination therapy for ethnic skin. Cutis. 2007;80(1 Suppl):15\u201320.","journal-title":"Cutis"},{"issue":"7","key":"333_CR81","first-page":"818","volume":"11","author":"LF Eichenfield","year":"2012","unstructured":"Eichenfield LF, Krakowski AC. Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel. J Drugs Dermatol. 2012;11(7):818\u201324.","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"333_CR82","first-page":"455","volume":"11","author":"FE Cook-Bolden","year":"2012","unstructured":"Cook-Bolden FE. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%\/benzoyl peroxide 2.5% gel. J Drugs Dermatol. 2012;11(4):455\u20139.","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"333_CR83","first-page":"643","volume":"11","author":"VD Callender","year":"2012","unstructured":"Callender VD. Fitzpatrick skin types and clindamycin phosphate 1.2%\/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne. J Drugs Dermatol. 2012;11(5):643\u20138.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"333_CR84","first-page":"607","volume":"6","author":"J Schlessinger","year":"2007","unstructured":"Schlessinger J, Menter A, Gold M, Leonardi C, Eichenfield L, Plott RT, et al. Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6(6):607\u201315.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"333_CR85","first-page":"197","volume":"15","author":"AF Alexis","year":"2016","unstructured":"Alexis AF, Burgess C, Callender VD, Herzog JL, Roberts WE, Schweiger ES, et al. The efficacy and safety of topical dapsone gel, 5% for the treatment of acne vulgaris in adult females with skin of color. J Drugs Dermatol. 2016;15(2):197\u2013204.","journal-title":"J Drugs Dermatol"},{"issue":"Suppl 3","key":"333_CR86","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.0926-9959.2001.00011.x","volume":"15","author":"WK Jacyk","year":"2001","unstructured":"Jacyk WK. Adapalene in the treatment of African patients. J Eur Acad Dermatol Venereol. 2001;15(Suppl 3):37\u201342.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"333_CR87","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-4165(91)90186-K","volume":"1073","author":"A Palumbo","year":"1991","unstructured":"Palumbo A, d\u2019Ischia M, Misuraca G, Prota G. Mechanism of inhibition of melanogenesis by hydroquinone. Biochem Biophys Acta. 1991;1073(1):85\u201390.","journal-title":"Biochem Biophys Acta"},{"issue":"6","key":"333_CR88","first-page":"1","volume":"9","author":"RM Halder","year":"2004","unstructured":"Halder RM, Richards GM. Topical agents used in the management of hyperpigmentation. Skin Therapy Lett. 2004;9(6):1\u20133.","journal-title":"Skin Therapy Lett."},{"issue":"4","key":"333_CR89","first-page":"365","volume":"81","author":"FE Cook-Bolden","year":"2008","unstructured":"Cook-Bolden FE, Hamilton SF. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation. Cutis. 2008;81(4):365\u201371.","journal-title":"Cutis"},{"key":"333_CR90","unstructured":"Baumann L, Grimes P, Pandya A. Triple combination cream is an effective treatment for post-inflammatory hyperpigmentation. In: Presented at the 65th Annual American Academy of Dermatology conference. 2007 February 3\u20135; Washington, DC."},{"issue":"3","key":"333_CR91","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40257-015-0126-8","volume":"16","author":"BJ Simmons","year":"2015","unstructured":"Simmons BJ, Griffith RD, Bray FN, Falto-Aizpurua LA, Nouri K. Exogenous ochronosis: a comprehensive review of the diagnosis, epidemiology, causes, and treatments. Am J Clin Dermatol. 2015;16(3):205\u201312.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"333_CR92","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00128071-200910040-00005","volume":"10","author":"HY Kang","year":"2009","unstructured":"Kang HY, Valerio L, Bahadoran P, Ortonne JP. The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review. Am J Clin Dermatol. 2009;10(4):251\u201360.","journal-title":"Am J Clin Dermatol"},{"issue":"4 Pt 2","key":"333_CR93","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0190-9622(86)70236-3","volume":"15","author":"PM Elias","year":"1986","unstructured":"Elias PM. Epidermal effects of retinoids: supramolecular observations and clinical implications. J Am Acad Dermatol. 1986;15(4 Pt 2):797\u2013809.","journal-title":"J Am Acad Dermatol"},{"key":"333_CR94","doi-asserted-by":"crossref","first-page":"AB194","DOI":"10.1016\/j.jaad.2005.10.064","volume":"54","author":"S Taylor","year":"2006","unstructured":"Taylor S, Callender V. A multicenter, 12-week, phase 3b trial: a combination solution of mequinol 2%\/tretinon 0.01% vs. hydroquinone 4% cream in the treatment of mild to moderate postinflammatory hyperpigmentation [Abstract]. J Am Acad Dermatol. 2006;54:AB194.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"333_CR95","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00006534-200003000-00040","volume":"105","author":"K Yoshimura","year":"2000","unstructured":"Yoshimura K, Harii K, Aoyama T, Iga T. Experience with a strong bleaching treatment for skin hyperpigmentation in orientals. Plast Reconstr Surg. 2000;105(3):1097\u2013108.","journal-title":"Plast Reconstr Surg."},{"issue":"9","key":"333_CR96","first-page":"964","volume":"14","author":"BC Schulte","year":"2015","unstructured":"Schulte BC, Wu W, Rosen T. Azelaic acid: evidence-based update on mechanism of action and clinical application. J Drugs Dermatol. 2015;14(9):964\u20138.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"333_CR97","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF00372617","volume":"282","author":"KU Schallreuter","year":"1990","unstructured":"Schallreuter KU, Wood JW. A possible mechanism of action for azelaic acid in the human epidermis. Arch Dermatol Res. 1990;282(3):168\u201371.","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"333_CR98","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2133.1984.tb04025.x","volume":"111","author":"AS Breathnach","year":"1984","unstructured":"Breathnach AS, Nazzaro-Porro M, Passi S. Azelaic acid. Br J Dermatol. 1984;111(1):115\u201320.","journal-title":"Br J Dermatol"},{"issue":"2","key":"333_CR99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-4362.1995.tb03583.x","volume":"34","author":"QH Nguyen","year":"1995","unstructured":"Nguyen QH, Bui TP. Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Int J Dermatol. 1995;34(2):75\u201384.","journal-title":"Int J Dermatol"},{"issue":"5","key":"333_CR100","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0149-2918(98)80077-5","volume":"20","author":"LS Kakita","year":"1998","unstructured":"Kakita LS, Lowe NJ. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone. Clin Ther. 1998;20(5):960\u201370.","journal-title":"Clin Ther."},{"issue":"9 Suppl","key":"333_CR101","first-page":"s123","volume":"12","author":"AF Alexis","year":"2013","unstructured":"Alexis AF, Blackcloud P. Natural ingredients for darker skin types: growing options for hyperpigmentation. J Drugs Dermatol. 2013;12(9 Suppl):s123\u20137.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"333_CR102","first-page":"13","volume":"7","author":"M Nestor","year":"2014","unstructured":"Nestor M, Bucay V, Callender V, Cohen JL, Sadick N, Waldorf H. Polypodium leucotomos as an adjunct treatment of pigmentary disorders. J Clin Aesthet Dermatol. 2014;7(3):13\u20137.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"4","key":"333_CR103","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1524-4725.1999.08236.x","volume":"25","author":"JT Lim","year":"1999","unstructured":"Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg. 1999;25(4):282\u20134.","journal-title":"Dermatol Surg"},{"issue":"5","key":"333_CR104","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1524-4725.1996.tb00345.x","volume":"22","author":"A Garcia","year":"1996","unstructured":"Garcia A, Fulton JE Jr. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg. 1996;22(5):443\u20137.","journal-title":"Dermatol Surg"},{"issue":"4","key":"333_CR105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-4362.2000.00943.x","volume":"39","author":"M Amer","year":"2000","unstructured":"Amer M, Metwalli M. Topical liquiritin improves melasma. Int J Dermatol. 2000;39(4):299\u2013301.","journal-title":"Int J Dermatol"},{"issue":"8","key":"333_CR106","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.0906-6705.2005.00337.x","volume":"14","author":"RE Boissy","year":"2005","unstructured":"Boissy RE, Visscher M, DeLong MA. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp Dermatol. 2005;14(8):601\u20138.","journal-title":"Exp Dermatol"},{"issue":"1","key":"333_CR107","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1365-2133.2002.04834.x","volume":"147","author":"T Hakozaki","year":"2002","unstructured":"Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20\u201331.","journal-title":"Br J Dermatol"},{"issue":"1","key":"333_CR108","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0378-6323.58674","volume":"76","author":"HR Jerajani","year":"2010","unstructured":"Jerajani HR, Mizoguchi H, Li J, Whittenbarger DJ, Marmor MJ. The effects of a daily facial lotion containing vitamins B3 and E and provitamin B5 on the facial skin of Indian women: a randomized, double-blind trial. Indian J Dermatol Venereol Leprol. 2010;76(1):20\u20136.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"333_CR109","doi-asserted-by":"crossref","first-page":"379173","DOI":"10.1155\/2011\/379173","volume":"2011","author":"J Navarrete-Solis","year":"2011","unstructured":"Navarrete-Solis J, Castanedo-Cazares JP, Torres-Alvarez B, Oros-Ovalle C, Fuentes-Ahumada C, Gonzalez FJ, et al. A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Dermatol Res Pract. 2011;2011:379173.","journal-title":"Dermatol Res Pract."},{"issue":"2","key":"333_CR110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2133.2009.09477.x","volume":"162","author":"AB Kimball","year":"2010","unstructured":"Kimball AB, Kaczvinsky JR, Li J, Robinson LR, Matts PJ, Berge CA, et al. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial. Br J Dermatol. 2010;162(2):435\u201341.","journal-title":"Br J Dermatol"},{"issue":"3","key":"333_CR111","doi-asserted-by":"crossref","first-page":"439.e1","DOI":"10.1016\/j.jaad.2006.10.005","volume":"56","author":"ZD Draelos","year":"2007","unstructured":"Draelos ZD, Carter E, Maloney JM, Elewski B, Poulin Y, Lynde C, et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56(3):439.e1\u2013510.e1.","journal-title":"J Am Acad Dermatol."},{"issue":"8","key":"333_CR112","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-4632.2004.02134.x","volume":"43","author":"LE Espinal-Perez","year":"2004","unstructured":"Espinal-Perez LE, Moncada B, Castanedo-Cazares JP. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol. 2004;43(8):604\u20137.","journal-title":"Int J Dermatol"},{"issue":"1","key":"333_CR113","first-page":"45","volume":"12","author":"MB Taylor","year":"2013","unstructured":"Taylor MB, Yanaki JS, Draper DO, Shurtz JC, Coglianese M. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic\/malic acid skin care regimen. J Drugs Dermatol. 2013;12(1):45\u201350.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"333_CR114","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sjbs.2015.01.016","volume":"23","author":"SJ Lee","year":"2016","unstructured":"Lee SJ, Hossaine MD, Park SC. A potential anti-inflammation activity and depigmentation effect of Lespedeza bicolor extract and its fractions. Saudi J Biol Sci. 2016;23(1):9\u201314.","journal-title":"Saudi J Biol Sci."},{"issue":"1","key":"333_CR115","first-page":"21","volume":"73","author":"EL Tanzi","year":"2004","unstructured":"Tanzi EL, Alster TS. Cutaneous laser surgery in darker skin phototypes. Cutis. 2004;73(1):21\u20134 (7\u201330).","journal-title":"Cutis."},{"issue":"2","key":"333_CR116","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/dth.12080","volume":"27","author":"KY Park","year":"2014","unstructured":"Park KY, Choi SY, Mun SK, Kim BJ, Kim MN. Combined treatment with 578-\/511-nm copper bromide laser and light-emitting diodes for post-laser pigmentation: a report of two cases. Dermatol Ther. 2014;27(2):121\u20135.","journal-title":"Dermatol Ther."},{"issue":"1","key":"333_CR117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lsm.10139","volume":"32","author":"WS Ho","year":"2003","unstructured":"Ho WS, Chan HH, Ying SY, Chan PC, Burd A, King WW. Prospective study on the treatment of postburn hyperpigmentation by intense pulsed light. Lasers Surg Med. 2003;32(1):42\u20135.","journal-title":"Lasers Surg Med"},{"issue":"10","key":"333_CR118","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1468-3083.2009.03123.x","volume":"23","author":"SB Cho","year":"2003","unstructured":"Cho SB, Park SJ, Kim JS, Kim MJ, Bu TS. Treatment of post-inflammatory hyperpigmentation using 1064-nm Q-switched Nd: YAG laser with low fluence: report of three cases. J Eur Acad Dermatol Venereol. 2009;23(10):1206\u20137. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03123.x .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"333_CR119","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/0974-2077.172196","volume":"8","author":"VP Zawar","year":"2015","unstructured":"Zawar VP, Agarwal M, Vasudevan B. Treatment of postinflammatory pigmentation due to acne with Q-Switched neodymium-doped yttrium aluminum garnet in 78 Indian cases. J Cutan Aesthet Surg. 2015;8(4):222\u20136.","journal-title":"J Cutan Aesthet Surg."},{"issue":"7","key":"333_CR120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archderm.136.7.915","volume":"136","author":"AJ Stratigos","year":"2000","unstructured":"Stratigos AJ, Dover JS, Arndt KA. Laser treatment of pigmented lesions\u20132000: how far have we gone? Arch Dermatol. 2000;136(7):915\u201321.","journal-title":"Arch Dermatol"},{"issue":"11","key":"333_CR121","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/j.1524-4725.2009.01303.x","volume":"35","author":"TM Katz","year":"2009","unstructured":"Katz TM, Goldberg LH, Firoz BF, Friedman PM. Fractional photothermolysis for the treatment of postinflammatory hyperpigmentation. Dermatol Surg. 2009;35(11):1844\u20138.","journal-title":"Dermatol Surg"},{"issue":"3","key":"333_CR122","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1524-4725.2009.01090.x","volume":"35","author":"CK Rokhsar","year":"2009","unstructured":"Rokhsar CK, Ciocon DH. Fractional photothermolysis for the treatment of postinflammatory hyperpigmentation after carbon dioxide laser resurfacing. Dermatol Surg. 2009;35(3):535\u20137.","journal-title":"Dermatol Surg"},{"issue":"4","key":"333_CR123","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1473-2165.2010.00527.x","volume":"9","author":"S Kim","year":"2010","unstructured":"Kim S, Cho KH. Treatment of procedure-related postinflammatory hyperpigmentation using 1064-nm Q-switched Nd: YAG laser with low fluence in Asian patients: report of five cases. J Cosmet Dermatol. 2010;9(4):302\u20136.","journal-title":"J Cosmet Dermatol."},{"issue":"2","key":"333_CR124","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/14764172.2015.1114634","volume":"18","author":"YB Lee","year":"2016","unstructured":"Lee YB, Park SM, Kim JW, Yu DS. Combination treatment of low-fluence Q-switched Nd: YAG laser and oral tranexamic acid for post-inflammatory hyperpigmentation due to allergic contact dermatitis to henna hair dye. J Cosmet Laser Ther. 2016;18(2):95\u20137.","journal-title":"J Cosmet Laser Ther."},{"issue":"2","key":"333_CR125","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jamadermatol.2016.4399","volume":"153","author":"O Agbai","year":"2016","unstructured":"Agbai O, Hamzavi I, Jagdeo J. Laser treatments for postinflammatory hyperpigmentation: a systematic review. JAMA Dermatol. 2017;153(2):199\u2013206. https:\/\/doi.org\/10.1001\/jamadermatol.2016.4399","journal-title":"JAMA Dermatol"},{"issue":"1","key":"333_CR126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/lsm.21010","volume":"43","author":"SG Ho","year":"2011","unstructured":"Ho SG, Yeung CK, Chan NP, Shek SY, Kono T, Chan HH. A retrospective analysis of the management of acne post-inflammatory hyperpigmentation using topical treatment, laser treatment, or combination topical and laser treatments in oriental patients. Lasers Surg Med. 2011;43(1):1\u20137.","journal-title":"Lasers Surg Med"},{"issue":"11","key":"333_CR127","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1524-4725.1995.tb00545.x","volume":"21","author":"D Kopera","year":"1995","unstructured":"Kopera D, Hohenleutner U. Ruby laser treatment of melasma and postinflammatory hyperpigmentation. Dermatol Surg. 1995;21(11):994.","journal-title":"Dermatol Surg"},{"issue":"9","key":"333_CR128","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1524-4725.1994.tb00152.x","volume":"20","author":"CR Taylor","year":"1994","unstructured":"Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol. 1994;20(9):592\u20137.","journal-title":"J Dermatol Surg Oncol."},{"issue":"2","key":"333_CR129","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2230.2005.02029.x","volume":"31","author":"A Mitra","year":"2006","unstructured":"Mitra A, Yeung R, Sheehan-Dare R, Wilson CL. Lentiginous hyperpigmentation confined to resolved psoriatic plaques and treated with a Q-switched ruby laser. Clin Exp Dermatol. 2006;31(2):298\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"333_CR130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/14764172.2013.854121","volume":"16","author":"SJ Lee","year":"2014","unstructured":"Lee SJ, Chung WS, Lee JD, Kim HS. A patient with cupping-related post-inflammatory hyperpigmentation successfully treated with a 1,927 nm thulium fiber fractional laser. J Cosmet Laser Ther. 2014;16(2):66\u20138.","journal-title":"J Cosmet Laser Ther."},{"issue":"2","key":"333_CR131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/09546630902936794","volume":"21","author":"SB Cho","year":"2010","unstructured":"Cho SB, Lee SJ, Kang JM, Kim YK, Oh SH. Treatment of refractory arcuate hyperpigmentation using a fractional photothermolysis system. J Dermatolog Treat. 2010;21(2):107\u20138.","journal-title":"J Dermatolog Treat."},{"key":"333_CR132","first-page":"986","volume":"43","author":"J Waibel","year":"2011","unstructured":"Waibel J, Wasserman D, Houshmand E, Tierney E. Treatment of post-inflammatory hyperpigmentation with 1927 nm thulium fractional laser [abstract]. Lasers Surg Med. 2011;43:986.","journal-title":"Lasers Surg Med"},{"issue":"5","key":"333_CR133","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/09546634.2011.565016","volume":"23","author":"MW Kroon","year":"2012","unstructured":"Kroon MW, Wind BS, Meesters AA, Wolkerstorfer A, van der Veen JP, Bos JD, et al. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study. J Dermatol Treat. 2012;23(5):339\u201344.","journal-title":"J Dermatol Treat"},{"issue":"3","key":"333_CR134","first-page":"42","volume":"7","author":"Y Oram","year":"2014","unstructured":"Oram Y, Akkaya AD. Refractory postinflammatory hyperpigmentation treated fractional CO2 laser. J Clin Aesthet Dermatol. 2014;7(3):42\u20134.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"1","key":"333_CR135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/14764172.2014.968576","volume":"17","author":"A Augustyniak","year":"2015","unstructured":"Augustyniak A, Erkiert-Polguj A, Rotsztejn H. Variable pulsed light treatment of melasma and post-inflammatory hyperpigmentation\u2014a pilot study. J Cosmet Laser Ther. 2015;17(1):15\u20139.","journal-title":"J Cosmet Laser Ther."},{"issue":"4","key":"333_CR136","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/DSS.0000000000001007","volume":"43","author":"R Sarkar","year":"2017","unstructured":"Sarkar R, Parmar NV, Kapoor S. Treatment of postinflammatory hyperpigmentation with a combination of glycolic acid peels and a topical regimen in dark-skinned patients: a comparative study. Dermatol Surg. 2017;43(4):566\u201373.","journal-title":"Dermatol Surg"},{"issue":"2","key":"333_CR137","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1396-0296.2004.04020.x","volume":"17","author":"WE Roberts","year":"2004","unstructured":"Roberts WE. Chemical peeling in ethnic\/dark skin. Dermatol Ther. 2004;17(2):196\u2013205.","journal-title":"Dermatol Ther"},{"issue":"3","key":"333_CR138","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1524-4725.1997.tb00014.x","volume":"23","author":"RL Burns","year":"1997","unstructured":"Burns RL, Prevost-Blank PL, Lawry MA, Lawry TB, Faria DT, Fivenson DP. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study. Dermatol Surg. 1997;23(3):171\u20134 (discussion 5).","journal-title":"Dermatol Surg."},{"issue":"10","key":"333_CR139","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1346-8138.2003.tb00474.x","volume":"30","author":"VN Sehgal","year":"2003","unstructured":"Sehgal VN, Luthra A, Aggarwal AK. Evaluation of graded strength glycolic acid (GA) facial peel: an Indian experience. J Dermatol. 2003;30(10):758\u201361.","journal-title":"J Dermatol"},{"issue":"1","key":"333_CR140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0094-1298(20)30769-0","volume":"20","author":"PE Grimes","year":"1993","unstructured":"Grimes PE, Hunt SG. Considerations for cosmetic surgery in the black population. Clin Plast Surg. 1993;20(1):27\u201334.","journal-title":"Clin Plast Surg"},{"issue":"1","key":"333_CR141","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jocd.12301","volume":"16","author":"BM Mohamed Ali","year":"2017","unstructured":"Mohamed Ali BM, Gheida SF, El Mahdy NA, Sadek SN. Evaluation of salicylic acid peeling in comparison with topical tretinoin in the treatment of postinflammatory hyperpigmentation. J Cosmet Dermatol. 2017;16(1):52\u201360.","journal-title":"J Cosmet Dermatol."},{"issue":"3","key":"333_CR142","first-page":"372","volume":"32","author":"HH Ahn","year":"2006","unstructured":"Ahn HH, Kim IH. Whitening effect of salicylic acid peels in Asian patients. Dermatol Surg. 2006;32(3):372\u20135 (discussion 5).","journal-title":"Dermatol Surg."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-017-0333-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0333-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0333-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T21:57:51Z","timestamp":1660082271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-017-0333-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":142,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1007\/s40257-017-0333-6","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}